Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder

Katja Häkkinen; Wilma Kiander; Heidi Kidron; Markku Lähteenvuo; Lea Urpa; Jonne Lintunen; Kati-Sisko Vellonen; Seppo Auriola; Minna Holm; Kaisla Lahdensuo; Olli Kampman; Erkki Isometsä; Tuula Kieseppä; Jouko Lönnqvist; Jaana Suvisaari; Jarmo Hietala; Jari Tiihonen; Aarno Palotie; Ari V. Ahola-Olli; Mikko Niemi

doi:10.1021/acs.molpharmaceut.2c00715

Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder

Katja Häkkinen, Wilma Kiander, Heidi Kidron, Markku Lähteenvuo, Lea Urpa, Jonne Lintunen, Kati-Sisko Vellonen, Seppo Auriola, Minna Holm, Kaisla Lahdensuo, Olli Kampman, Erkki Isometsä, Tuula Kieseppä, Jouko Lönnqvist, Jaana Suvisaari, Jarmo Hietala, Jari Tiihonen, Aarno Palotie, Ari V. Ahola-Olli, Mikko Niemi

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Molecular Pharmaceutics
Volume	20
Issue number	3
Pages (from-to)	1500–1508
Number of pages	9
ISSN	1543-8384
DOIs	https://doi.org/10.1021/acs.molpharmaceut.2c00715
Publication status	Published - 6 Mar 2023
MoE publication type	A1 Journal article-refereed

Fields of Science

317 Pharmacy

Access to Document

10.1021/acs.molpharmaceut.2c00715Licence: CC BY

häkkinen-et-al-2023-functional-characterization-of-six-slco1b1-(oatp1b1)-variants-observed-in-finnish-individuals-withFinal published version, 3.26 MBLicence: CC BY

Cite this

Häkkinen, K., Kiander, W., Kidron, H., Lähteenvuo, M., Urpa, L., Lintunen, J., Vellonen, K.-S., Auriola, S., Holm, M., Lahdensuo, K., Kampman, O., Isometsä, E., Kieseppä, T., Lönnqvist, J., Suvisaari, J., Hietala, J., Tiihonen, J., Palotie, A., Ahola-Olli, A. V., & Niemi, M. (2023). Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder. Molecular Pharmaceutics, 20(3), 1500–1508. https://doi.org/10.1021/acs.molpharmaceut.2c00715

@article{878725bf709e4e1fa4b1f6dbb32e6387,

title = "Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder",

keywords = "Drug transporter, Pharmacogenetics, 317 Pharmacy",

author = "Katja H{\"a}kkinen and Wilma Kiander and Heidi Kidron and Markku L{\"a}hteenvuo and Lea Urpa and Jonne Lintunen and Kati-Sisko Vellonen and Seppo Auriola and Minna Holm and Kaisla Lahdensuo and Olli Kampman and Erkki Isomets{\"a} and Tuula Kiesepp{\"a} and Jouko L{\"o}nnqvist and Jaana Suvisaari and Jarmo Hietala and Jari Tiihonen and Aarno Palotie and Ahola-Olli, {Ari V.} and Mikko Niemi",

year = "2023",

month = mar,

day = "6",

doi = "10.1021/acs.molpharmaceut.2c00715",

language = "English",

volume = "20",

pages = "1500–1508",

journal = "Molecular Pharmaceutics",

issn = "1543-8384",

publisher = "American Chemical Society",

number = "3",

}

Häkkinen, K, Kiander, W , Kidron, H, Lähteenvuo, M, Urpa, L, Lintunen, J, Vellonen, K-S, Auriola, S, Holm, M, Lahdensuo, K, Kampman, O , Isometsä, E , Kieseppä, T , Lönnqvist, J, Suvisaari, J, Hietala, J, Tiihonen, J, Palotie, A, Ahola-Olli, AV & Niemi, M 2023, 'Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder', Molecular Pharmaceutics, vol. 20, no. 3, pp. 1500–1508. https://doi.org/10.1021/acs.molpharmaceut.2c00715

TY - JOUR

T1 - Functional Characterization of Six SLCO1B1 (OATP1B1) Variants Observed in Finnish Individuals with a Psychotic Disorder

AU - Häkkinen, Katja

AU - Kiander, Wilma

AU - Kidron, Heidi

AU - Lähteenvuo, Markku

AU - Urpa, Lea

AU - Lintunen, Jonne

AU - Vellonen, Kati-Sisko

AU - Auriola, Seppo

AU - Holm, Minna

AU - Lahdensuo, Kaisla

AU - Kampman, Olli

AU - Isometsä, Erkki

AU - Kieseppä, Tuula

AU - Lönnqvist, Jouko

AU - Suvisaari, Jaana

AU - Hietala, Jarmo

AU - Tiihonen, Jari

AU - Palotie, Aarno

AU - Ahola-Olli, Ari V.

AU - Niemi, Mikko

PY - 2023/3/6

Y1 - 2023/3/6

KW - Drug transporter

KW - Pharmacogenetics

KW - 317 Pharmacy

U2 - 10.1021/acs.molpharmaceut.2c00715

DO - 10.1021/acs.molpharmaceut.2c00715

M3 - Article

C2 - 36779498

SN - 1543-8384

VL - 20

SP - 1500

EP - 1508

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

IS - 3

ER -